Lo Y.LIAN-YU LINTSEN-FANG TSAI2021-10-282021-10-2820211751-2433https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101774800&doi=10.1080%2f17512433.2021.1894128&partnerID=40&md5=c843f2c7e5d085f268f70b348e972240https://scholars.lib.ntu.edu.tw/handle/123456789/585988Introduction: Calcium channel blockers (CCB) are commonly used for cardiovascular diseases. The evidence supporting the use of CCB in dermatology is mostly anecdotal and limited to case reports or small case series. Areas covered: This review article is dadverse drug reaction; Calcium channel blockers; cutaneous reaction; dermatology; treatment[SDGs]SDG3calcium channel blocking agent; vismodegib; calcium channel blocking agent; dermatological agent; anus fissure; atrophie blanche; chilblain lupus erythematosus; chronic disease; decubitus; dermatology; drug induced disease; eczema; face; fibromatosis; ginreview10.1080/17512433.2021.1894128336120362-s2.0-85101774800